Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CeraShield is a biotechnology company specializing in the development of advanced antimicrobial surface treatments designed to prevent healthcare-associated infections. The company's proprietary technology involves a ceramic-based coating that can be applied to medical devices such as catheters and surgical implants to inhibit the formation of bacterial biofilms. By addressing the root cause of device-related infections, CeraShield aims to improve patient outcomes and significantly reduce the economic burden on healthcare systems. The company is currently advancing its lead programs through pre-clinical validation and is actively seeking partnerships for commercial integration across the medical device industry. Its solutions are designed to be biocompatible and durable, providing long-lasting protection against a wide range of pathogens.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CeraShield.